{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T01:14:14Z","timestamp":1783300454766,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute of Health (NIH), United States","award":["1R01CA251792-01A1"],"award-info":[{"award-number":["1R01CA251792-01A1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15904-8","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:17:31Z","timestamp":1778487451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Involved nodal versus elective neck radiotherapy (INVERT) for head and neck squamous cell carcinoma: a prospective phase II randomized controlled trial protocol"],"prefix":"10.1186","volume":"26","author":[{"given":"Sympascho","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic H.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"15904_CR1","doi-asserted-by":"crossref","unstructured":"Safavi AH, Lee NY, Tsai CJ. Principles and Paradigms of De-Escalated Elective Nodal Irradiation: Boldly Going Towards an Inflection Point in Head and Neck Radiotherapy. Seminars in Radiation Oncology. Volume 35. W.B. Saunders; 2025. pp. 143\u201356.","DOI":"10.1016\/j.semradonc.2025.01.001"},{"key":"15904_CR2","doi-asserted-by":"crossref","unstructured":"Haderlein M, Frei C, Weissmann T, Weber M, Lutz R, Gostian AO et al. Is less more? Revisiting elective nodal irradiation in head and neck cancer. Strahlenther Onkol [Internet]. 2025 Nov 1 [cited 2025 Nov 3];201(11). Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca\/40705060\/","DOI":"10.1007\/s00066-025-02437-5"},{"key":"15904_CR3","doi-asserted-by":"crossref","unstructured":"Chen M, Bao Y, Ma HL, Hu X, Wang J, Wang Y et al. Involved-Field Radiotherapy versus Elective Nodal Irradiation in Combination with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study. Biomed Res Int [Internet]. 2013 [cited 2025 Nov 3];2013:371819. Available from: https:\/\/pmc-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca\/articles\/PMC3666303\/","DOI":"10.1155\/2013\/371819"},{"key":"15904_CR4","unstructured":"Girinsky T, Van Der Maazen R, Specht L, Aleman B, Poortmans P, Lievens Y et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines. [cited 2025 Nov 3]; Available from: www.thegreenjournal.com."},{"key":"15904_CR5","doi-asserted-by":"crossref","unstructured":"Sher DJ, Pham NL, Shah JL, Sen N, Williams KA, Subramaniam RM et al. Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer. Int J Radiat Oncol Biol Phys [Internet]. 2021 Mar 15 [cited 2025 Oct 5];109(4):932\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33127491\/","DOI":"10.1016\/j.ijrobp.2020.09.063"},{"issue":"3","key":"15904_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/jamaoncol.2021.6416","volume":"8","author":"CJ Tsai","year":"2022","unstructured":"Tsai CJ, McBride SM, Riaz N, Kang JJ, Spielsinger DJ, Waldenberg T, et al. Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. JAMA Oncol. 2022;8(3):364\u201372.","journal-title":"JAMA Oncol"},{"key":"15904_CR7","doi-asserted-by":"crossref","unstructured":"Nevens D, Duprez F, Daisne JF, Schatteman J, Van der Vorst A, De Neve W et al. Recurrence patterns after a decreased dose of 40 Gy to the elective treated neck in head and neck cancer. Radiotherapy and Oncology [Internet]. 2017 Jun 1 [cited 2025 Nov 4];123(3):419\u201323. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0167814017300993","DOI":"10.1016\/j.radonc.2017.03.003"},{"issue":"23","key":"15904_CR8","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1200\/JCO-24-02194","volume":"43","author":"S van den Bosch","year":"2025","unstructured":"van den Bosch S, Doornaert PAH, Hoebers FJP, Kreike B, Vergeer MR, Zwijnenburg EM, et al. Clinical Benefit and Safety of Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma: The UPGRADE-RT Multicenter Randomized Controlled Trial. J Clin Oncol. 2025;43(23):2583\u201394.","journal-title":"J Clin Oncol"},{"key":"15904_CR9","doi-asserted-by":"crossref","unstructured":"Zakeri K, Wren SD, Shang T, Yu Y, Chen L, Shamseddine A et al. Outcomes of Reduced Elective Nodal Radiation Dose and Volume for Laryngeal, Hypopharyngeal, and p16-Negative Oropharyngeal Cancers. Head Neck [Internet]. 2025 Nov 1 [cited 2025 Nov 4];47(11). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40515499\/","DOI":"10.1002\/hed.28217"},{"key":"15904_CR10","doi-asserted-by":"crossref","unstructured":"Chen L, Zhou Z, Sher D, Zhang Q, Shah J, Pham NL et al. Combining Many-objective Radiomics and 3-dimensional Convolutional Neural Network through Evidential Reasoning to Predict Lymph Node Metastasis in Head and Neck Cancer. Phys Med Biol [Internet]. 2019 Mar 29 [cited 2025 Nov 2];64(7). Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca\/30780137\/","DOI":"10.1088\/1361-6560\/ab083a"},{"issue":"17","key":"15904_CR11","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1158\/1078-0432.CCR-23-0334","volume":"29","author":"DJ Sher","year":"2023","unstructured":"Sher DJ, Moon DH, Vo D, Wang J, Chen L, Dohopolski M, et al. Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical Trial. Clin Cancer Res. 2023;29(17):3284\u201391.","journal-title":"Clin Cancer Res"},{"key":"15904_CR12","doi-asserted-by":"crossref","unstructured":"Sher DJ, Avkshtol V, Lin MH, Wang J, Chen L, Liao CY et al. Impact of daily adaptive head and neck radiotherapy on toxicity and quality-of-life: results of the DARTBOARD phase II randomized trial. JNCI: J Natl Cancer Inst. 2025.","DOI":"10.1093\/jnci\/djaf232"},{"key":"15904_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","volume":"134","author":"J Biau","year":"2019","unstructured":"Biau J, Lapeyre M, Troussier I, Budach W, Giralt J, Grau C, et al. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019;134:1\u20139.","journal-title":"Radiother Oncol"},{"key":"15904_CR14","doi-asserted-by":"crossref","unstructured":"Darragh LB, Gadwa J, Pham TT, Van Court B, Neupert B, Olimpo NA et al. Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors. Nat Commun [Internet]. 2022 Dec 1 [cited 2025 Nov 2];13(1). Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca\/36385142\/","DOI":"10.1038\/s41467-022-34676-w"},{"key":"15904_CR15","doi-asserted-by":"crossref","unstructured":"Mickel TA, Moon DH, Avkshtol V, Pham NL, Shah JL, Hughes RS et al. Relationship Between Elective Neck Irradiation and Severe Lymphopenia in Patients Treated With Head and Neck Chemoradiotherapy. Clin Oncol [Internet]. 2025 Aug 1 [cited 2025 Nov 2];44. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca\/40499199\/","DOI":"10.1016\/j.clon.2025.103873"},{"key":"15904_CR16","doi-asserted-by":"crossref","unstructured":"Reyes-Chicuellar N, Kagan R, Friedland P. Prognostic impact of neutrophil-lymphocyte ratio in head and neck cancer: a decade of evidence. Australian Journal of Otolaryngology [Internet]. 2025 Mar 30 [cited 2025 Nov 3];8(0). Available from: https:\/\/www.theajo.com\/article\/view\/4897\/html","DOI":"10.21037\/ajo-24-52"},{"key":"15904_CR17","doi-asserted-by":"crossref","unstructured":"Campian JL, Sarai G, Ye X, Marur S, Grossman SA. The association between severe treatment-related lymphopenia and progression free survival in patients with newly diagnosed squamous cell head and neck cancer. Head Neck [Internet]. 2014 Dec 1 [cited 2025 Nov 3];36(12):1747. Available from: https:\/\/pmc-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca\/articles\/PMC4081494\/","DOI":"10.1002\/hed.23535"},{"issue":"2","key":"15904_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijrobp.2023.04.029","volume":"117","author":"TM Ma","year":"2023","unstructured":"Ma TM, Wong DJ, Chai-Ho W, Mendelsohn A, St. John M, Abemayor E, et al. High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib\/II Clinical Trial. Int J Radiat Oncol Biol Phys. 2023;117(2):348\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15904_CR19","doi-asserted-by":"crossref","unstructured":"Van Den Bosch S, Dijkema T, Verhoef LCG, Zwijnenburg EM, Janssens GO, Kaanders JHAM. Patterns of recurrence in electively irradiated lymph node regions after definitive accelerated intensity modulated radiation therapy for head and neck squamous cell Carcinoma. Int J Radiat Oncol Biol Phys [Internet]. 2016 Mar 15 [cited 2025 Oct 5];94(4):766\u201374. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26972649\/","DOI":"10.1016\/j.ijrobp.2015.12.002"},{"key":"15904_CR20","doi-asserted-by":"crossref","unstructured":"Dohopolski M, Chen L, Sher D, Wang J. Predicting lymph node metastasis in patients with oropharyngeal cancer by using a convolutional neural network with associated epistemic and aleatoric uncertainty. Phys Med Biol [Internet]. 2020 Nov 1 [cited 2025 Nov 2];65(22). Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca\/33179605\/","DOI":"10.1088\/1361-6560\/abb71c"},{"key":"15904_CR21","doi-asserted-by":"crossref","unstructured":"Chen L, Dohopolski M, Zhou Z, Wang K, Wang R, Sher D et al. Attention Guided Lymph Node Malignancy Prediction in Head and Neck Cancer. Int J Radiat Oncol Biol Phys [Internet]. 2021 Jul 15 [cited 2025 Nov 2];110(4):1171\u20139. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca\/33561508\/","DOI":"10.1016\/j.ijrobp.2021.02.004"},{"key":"15904_CR22","unstructured":"Chen L, Radpour S, Dohopolski M, Sher D, Wang J. AI-Based Identification of Malignant Lymph Nodes with Uncertainty Awareness: A CT-Only Model for a Prospective Trial of Involved Nodal Versus Elective Neck Radiotherapy. IJROBP in review. 2025."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15904-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15904-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15904-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:16:51Z","timestamp":1783297011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15904-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15904"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15904-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved by the University of Texas Southwestern Medical Center institutional review board (approval number STU 2024\u2009\u2212\u20090603). The study adheres to the ethical guidelines outlined in the Declaration of Helsinki. Written, informed consent will be obtained from all participants prior to enrolment. Patients enrolled will be informed of all aspects of the study, including the potential risks and benefits involved. They will be given ample time and opportunity to ask questions prior to deciding about participating in the study and be informed that participation in the study is voluntary and that they are completely free to refuse to enter the study or to withdraw from it at any time, for any reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DJS and JW have filed a patent for systems, methods, and devices for characterizing lymph nodes with a multifaceted AIR model. DJS and JW also founded the company DAIgnosTX for further development, commercialization and distribution of the AIR model.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"815"}}